Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN.

Andriani A, Montanaro M, Voso MT, VillivĂ  N, Ciccone F, Andrizzi C, De Gregoris C, Di Veroli A, Maurillo L, Alimena G, Latagliata R.

Leuk Res. 2015 Aug;39(8):801-4. doi: 10.1016/j.leukres.2015.03.001. Epub 2015 Mar 19.

PMID:
26065981
2.

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.

Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, Dore F, Maresca M, Rapicetta M, Marcucci F, Mandelli F, Franceschi S.

Blood. 2003 Aug 1;102(3):996-9. Epub 2003 Apr 24.

PMID:
12714514
3.

Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.

Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G.

Bone Marrow Transplant. 1997 Sep;20(6):465-71.

4.

Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.

Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.

Haematologica. 1997 May-Jun;82(3):291-6.

5.

Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experience.

Vignetti M, Orsini E, Petti MC, Moleti ML, Andrizzi C, Pinto RM, Amadori S, Meloni G.

Ann Oncol. 1996 Nov;7(9):933-8.

PMID:
9006744
6.

Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases.

Meloni G, Vignetti M, Andrizzi C, Capria S, Foa R, Mandelli F.

Leuk Lymphoma. 1996 May;21(5-6):429-35.

PMID:
9172807
7.

Autoimmune hemolytic anemia in a patient with acute myelogenous leukemia treated with low-dose interleukin-2 after autologous bone marrow transplantation.

Meloni G, Andrizzi C, Vignetti M, Girelli G, Mandelli F.

Blood. 1995 Jul 15;86(2):837-8. No abstract available.

PMID:
7606020
8.

Interleukin 2 treatment in acute myelogenous leukemia.

Mandelli F, Vignetti M, Tosti S, Andrizzi C, Foa R, Meloni G.

Stem Cells. 1993 Jul;11(4):263-8. Review.

PMID:
8401249
9.

ABMT for children AML: Italian experience. GITMO-AIEOP Groups.

Meloni G, Vignetti M, Andrizzi C, Dallorso S, Bonetti F, Zanesco L, Madon E, Andolina M, Carella AM, De Laurenzi A, et al.

Bone Marrow Transplant. 1991;7 Suppl 3:80-3.

PMID:
1855095

Supplemental Content

Loading ...
Support Center